Synbiotic add-on for people with Parkinson’s disease
Part of Brain & nervous system clinical trials.
This trial tests whether adding a synbiotic (a mix of probiotics and prebiotics) along with standard Parkinson’s medicines can improve symptoms or health outcomes. It’s mainly for adults with Parkinson’s disease at earlier to mid-stages who take dopamine replacement therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 45 and 65 years old
- Have Parkinson’s disease and take dopamine replacement medicine
- Have Parkinson’s disease stage between MHY 1 and MHY 4
- Not have taken antibiotics in the past month
- Not have used probiotic products in the past 2 weeks
- Not be a smoker or have stage MHY 5
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether transplanting healthy gut bacteria from a donor can help reduce motor complications (like involuntary movements or on-off medication cycles) in people with Parkinson's disease who have had the condition for at least 5 years.
This Phase 2 study tests whether taking probiotics can improve depression and mood symptoms in people with Parkinson’s disease. It’s meant for those with mild to moderate depression and stable Parkinson’s and mood treatments.
This study tests whether a special blend of probiotics (good bacteria), an amino acid called tryptophan, and branched-chain amino acids can help slow the progression of early-stage Parkinson's disease. The idea is that these supplements may work through your gut bacteria to help protect your brain.
This study looks at how certain gut bacteria (methanogens) are involved in the progression of Parkinson's disease and related conditions. It aims to understand the connection between gut health and brain health, which may lead to better treatments.
This study explores how bacteria in the small intestine affect how well the Parkinson's medication L-dopa works. It involves swallowing a special capsule to collect gut samples.
This trial tests whether a daily supplement of friendly bacteria and prebiotics (called a synbiotic) can help people with Alzheimer's. It looks at how the supplement affects thinking, behavior, and daily life over time.
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.